Related Experiment Video
Updated: May 11, 2025

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Cardiac Effects in Children of Hypertensive Mothers: A Literature Review
Gabrielle Amar1, Josef Kusayev1, William H Frishman1
1From the Department of Medicine, New York Medical College, Valhalla, NY.
Insights
Preeclampsia (PE) in pregnancy can cause lasting heart changes in children, including structural and functional issues. More research is needed to understand these effects and enable early intervention for affected infants.
Area of Science:
- Cardiovascular Science
- Perinatal Medicine
- Developmental Biology
Background:
- Preeclampsia (PE) affects up to 8% of pregnancies, causing hypertension.
- In utero PE exposure is linked to cardiac changes in neonates, such as increased left ventricular mass and myocardial hypertrophy.
- Long-term cardiovascular effects in offspring are inconsistent, but some studies suggest persistent systolic and diastolic dysfunction into adulthood.
Purpose of the Study:
- To review the cardiac manifestations in offspring exposed to preeclampsia in utero.
- To highlight knowledge gaps regarding molecular pathways linking PE to offspring cardiovascular outcomes.
- To increase awareness for early intervention opportunities in this high-risk population.
Main Methods:
- Literature review synthesizing existing research on PE and offspring cardiovascular health.
- Analysis of studies investigating fetal developmental programming due to intrauterine conditions.
- Examination of evidence linking PE to altered cardiac remodeling and vascular resistance, independent of fetal growth restriction.
Main Results:
- Offspring exposed to PE exhibit cardiac structural and functional changes, including increased left ventricular mass and hypertrophy.
- Evidence suggests a potential for long-term cardiovascular risks, such as systolic and diastolic dysfunction, persisting into adolescence and adulthood.
- Mechanisms involved in PE's impact on offspring cardiovascular health include placental insufficiency, angiogenic imbalance, oxidative stress, and epigenetic modifications.
Conclusions:
- Preeclampsia exposure during pregnancy significantly impacts offspring cardiovascular development.
- Further research is crucial to elucidate the molecular pathways and long-term consequences.
- Early detection and intervention strategies are needed for infants born to mothers with preeclampsia.
Abstract:
Preeclampsia (PE), a hypertensive disorder affecting up to 8% of pregnancies, has been associated with cardiac structural and functional changes in offspring. Studies suggest that neonates exposed to PE in utero may exhibit increased left ventricular mass, myocardial hypertrophy, and disrupted myocardial compaction. However, the long-term cardiovascular effects remain inconsistent across studies, with some evidence indicating an elevated risk of systolic and diastolic dysfunction persisting into adolescence and adulthood. The multifactorial nature of PE complicates the establishment of clear causality, as mechanisms likely involve placental insufficiency, angiogenic imbalance, oxidative stress, and epigenetic modifications. Research indicates that fetal developmental programming due to adverse intrauterine conditions plays a critical role in shaping offspring cardiovascular outcomes. Independent of fetal growth restriction, PE exposure has been linked to altered cardiac remodeling and increased vascular resistance. Despite this growing body of evidence, knowledge gaps remain regarding the molecular pathways linking PE to cardiovascular outcomes in offspring. This review synthesizes findings on the cardiac manifestations of offspring exposed to PE and underscores the need for further research to better understand the interplay of maternal hypertension and fetal cardiovascular development. By increasing awareness among healthcare providers, this review aims to highlight opportunities for early intervention in this at-risk population.
Related Concept Videos
Hormonal Regulation
Hypertension and Regulation of Blood Pressure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antihypertensive Drugs: Types of β-Blockers

